California-based Orca Bio, focused on the development of precision cell therapies for cancer, genOrca Bio plans to build 100,000-sq ft commercial facility in Sacramento, Californiaetic blood disorders and autoimmune diseases, has drafted plans to build a new, 100,000-square-foot commercial facility in Sacramento, California.

The plant will be used to tackle the late-stage development of Orca’s pod of cell therapy prospects including Orca-T, the company’s most advanced allogeneic candidate, which is in phase 3 testing in a trio of blood cancers.

The plant will have the capacity to crank out roughly 3,000 cell therapy products per year, plus it will be equipped to scale to meet future demand, Orca co-founder and COO Jeroen Bekaert, said.

The facility will also contain quality control labs, warehouse space and offices.